Sodium Iodide I 123 (Cardinal Health 418, Inc)


Welcome to the PulseAid listing for the Sodium Iodide I 123 drug offered from Cardinal Health 418, Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health 418, Inc
NON-PROPRIETARY NAME: Sodium Iodide I 123
SUBSTANCE NAME: SODIUM IODIDE I-123
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-01-02
END MARKETING DATE: 0000-00-00


Sodium Iodide I 123 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Iodide I 123 from Cardinal Health 418, Inc
LABELER NAME: Cardinal Health 418, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 100(uCi/1)
START MARKETING DATE: 2003-01-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 48815-1001_9f74fdc8-f22c-45b2-ab88-dc8336d44d46
PRODUCT NDC: 48815-1001
APPLICATION NUMBER: NDA018671

Other SODIUM IODIDE I-123 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal Health 418, IncSodium Iodide I 123
MALLINCKRODT NUCLEAR MEDICINE LLCSODIUM IODIDE I 123